FGF10
Fibroblast growth factor 10 is a protein that in humans is encoded by the FGF10 gene.[5][6]
Function
[edit]The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. Fibroblast growth factor 10 is a paracrine signaling molecule seen first in the limb bud and organogenesis development. FGF10 starts the developing of limbs and its involved in the branching of morphogenesis in multiple organs such as the lungs, skin, ear and salivary glands. During the limb development Tbx4/Tbx5 stimulate the production of FGF10 in the lateral plate mesoderm where it will create an epithelial-mesenchymal FGF signal with FGF8. This positive feedback loop will increase the amount of mesenchyme resulting in a bulge. Afterwards, FGF10 will induce the formation of apical ectodermal ridge (AER) where the foot and hands will be formed. Lung development uses the same epithelial-mesenchymal signaling from FGF10 in the foregut mesenchyme with FGFR2 in the foregut epithelium. FGF10 signaling is required for epithelial branching. Therefore, all branching morphogen organs such as the lungs, skin, ear and salivary glands required the constant expression of FGF10. This protein exhibits mitogenic activity for keratinizing epidermal cells, but essentially no activity for fibroblasts, which is similar to the biological activity of FGF7.[6]
Clinical significance
[edit]Nonsense mutations may also occur with the absence of FGF10 such as LADD and ALSG syndrome. Nevertheless, complications may arise from FGF10 signaling such as pancreatic and breast cancer. Moreover, studies have identified variants near the FGF10 locus as a genetic risk factor for breast cancer susceptibility.[7] Although this gene is also implicated to be a primary factor in the process of wound healing.[6] Heterozygous FGF10 variants and childhood intestinal lung disease (child) linked to potential early lethal outcomes. Also, FGF10 variants have been associated with abnormal epithelial repair.[8] FGF10 haploinsufficiency have been shown to increased risk of chronic‐obstructive pulmonary disease (COPD). Individuals with haploinsufficiency for FGF10 have significantly reduced Tiffeneau index, resembling chronic restrictive and obstructive pulmonary disease. [9]
Animal studies
[edit]FGF10 knockout mice die right after birth. The mice showed no developing organs such as lungs, salivary glands, kidney or definitive limbs once autopsied. Studies of the mouse homolog suggested that this gene is required for embryonic epidermal morphogenesis including brain development, lung morphogenesis, and initiation of limb bud formation.[10] FGF Knockout mice also have impaired epicardial cell expansion following neonatal heart injury, as well as reduced expression of epicardial markers Wt1 and Tbx18, and mesenchymal markers such as Snai1, Twist1, and Postn.[11] Mice deficient for FGF10 fail to develop normal mammary glands. [12] Guinea Pig model has shown that FGF10 monoclonal antibody can decrease the number of inflammatory cells in the dermis and its inhibitory effect on inflammatory cells is like that of hydrocortisone butyrate. [13]
Interactions
[edit]FGF10 has been shown to interact with Heparan sulfate [14] and Toll-like receptors. [15]
See also
[edit]References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000070193 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021732 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Emoto H, Tagashira S, Mattei MG, Yamasaki M, Hashimoto G, Katsumata T, et al. (September 1997). "Structure and expression of human fibroblast growth factor-10". The Journal of Biological Chemistry. 272 (37): 23191–23194. doi:10.1074/jbc.272.37.23191. PMID 9287324.
- ^ a b c "Entrez Gene: FGF10 fibroblast growth factor 10".
- ^ Rivetti S, Chen C, Chen C, Bellusci S (2020-06-26). "Fgf10/Fgfr2b Signaling in Mammary Gland Development, Homeostasis, and Cancer". Frontiers in Cell and Developmental Biology. 8: 415. doi:10.3389/fcell.2020.00415. PMC 7333592. PMID 32676501.
- ^ Schütz K, Schmidt A, Schwerk N, Renz DM, Gerard B, Schaefer E, et al. (November 2023). "Variants in FGF10 cause early onset of severe childhood interstitial lung disease: A detailed description of four affected children". Pediatric Pulmonology. 58 (11): 3095–3105. doi:10.1002/ppul.26627. PMID 37560881.
- ^ Klar J, Blomstrand P, Brunmark C, Badhai J, Håkansson HF, Brange CS, et al. (October 2011). "Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease". Journal of Medical Genetics. 48 (10): 705–709. doi:10.1136/jmedgenet-2011-100166. PMID 21742743.
- ^ Itoh N, Ohta H (May 2014). "Fgf10: a paracrine-signaling molecule in development, disease, and regenerative medicine". Current Molecular Medicine. 14 (4): 504–509. doi:10.2174/1566524014666140414204829. PMID 24730525.
- ^ Clayton NS, Grose RP (2018-10-24). "Emerging Roles of Fibroblast Growth Factor 10 in Cancer". Frontiers in Genetics. 9: 499. doi:10.3389/fgene.2018.00499. PMC 6207577. PMID 30405704.
- ^ Mailleux AA, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, Itoh N, et al. (January 2002). "Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo". Development. 129 (1): 53–60. doi:10.1242/dev.129.1.53. PMID 11782400.
- ^ Xia JX, Mei XL, Zhu WJ, Li X, Jin XH, Mou Y, et al. (2014). "Effect of FGF10 monoclonal antibody on psoriasis-like model in guinea pigs". International Journal of Clinical and Experimental Pathology. 7 (5): 2219–2228. PMC 4069920. PMID 24966930.
- ^ Izvolsky KI, Shoykhet D, Yang Y, Yu Q, Nugent MA, Cardoso WV (June 2003). "Heparan sulfate-FGF10 interactions during lung morphogenesis". Developmental Biology. 258 (1): 185–200. doi:10.1016/S0012-1606(03)00114-3. PMID 12781692.
- ^ Liu L, Song C, Li J, Wang Q, Zhu M, Hu Y, et al. (January 2020). "Fibroblast growth factor 10 alleviates particulate matter-induced lung injury by inhibiting the HMGB1-TLR4 pathway". Aging. 12 (2): 1186–1200. doi:10.18632/aging.102676. PMC 7053597. PMID 31958320.
Further reading
[edit]- Igarashi M, Finch PW, Aaronson SA (May 1998). "Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7)". The Journal of Biological Chemistry. 273 (21): 13230–13235. doi:10.1074/jbc.273.21.13230. PMID 9582367.
- Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, et al. (January 1999). "Fgf10 is essential for limb and lung formation". Nature Genetics. 21 (1): 138–141. doi:10.1038/5096. PMID 9916808. S2CID 7296564.
- Jimenez PA, Rampy MA (February 1999). "Keratinocyte growth factor-2 accelerates wound healing in incisional wounds". The Journal of Surgical Research. 81 (2): 238–242. doi:10.1006/jsre.1998.5501. PMID 9927546.
- Ropiquet F, Giri D, Kwabi-Addo B, Schmidt K, Ittmann M (September 2000). "FGF-10 is expressed at low levels in the human prostate". The Prostate. 44 (4): 334–338. doi:10.1002/1097-0045(20000901)44:4<334::AID-PROS11>3.0.CO;2-G. PMID 10951499. S2CID 35828553.
- Marchese C, Felici A, Visco V, Lucania G, Igarashi M, Picardo M, et al. (April 2001). "Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes". The Journal of Investigative Dermatology. 116 (4): 623–628. doi:10.1046/j.0022-202x.2001.01280.x. PMID 11286634.
- Bagai S, Rubio E, Cheng JF, Sweet R, Thomas R, Fuchs E, et al. (June 2002). "Fibroblast growth factor-10 is a mitogen for urothelial cells". The Journal of Biological Chemistry. 277 (26): 23828–23837. doi:10.1074/jbc.M201658200. PMID 11923311.
- Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, et al. (March 2003). "Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors". Proceedings of the National Academy of Sciences of the United States of America. 100 (5): 2266–2271. Bibcode:2003PNAS..100.2266Y. doi:10.1073/pnas.0436500100. PMC 151329. PMID 12591959.
- Upadhyay D, Lecuona E, Comellas A, Kamp DW, Sznajder JI (June 2003). "Fibroblast growth factor-10 upregulates Na,K-ATPase via the MAPK pathway". FEBS Letters. 545 (2–3): 173–176. Bibcode:2003FEBSL.545..173U. doi:10.1016/S0014-5793(03)00527-1. PMID 12804770. S2CID 40221645.
- Izvolsky KI, Zhong L, Wei L, Yu Q, Nugent MA, Cardoso WV (October 2003). "Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching". American Journal of Physiology. Lung Cellular and Molecular Physiology. 285 (4): L838 – L846. doi:10.1152/ajplung.00081.2003. PMID 12818887. S2CID 23937684.
- Tomlinson DC, Grindley JC, Thomson AA (April 2004). "Regulation of Fgf10 gene expression in the prostate: identification of transforming growth factor-beta1 and promoter elements". Endocrinology. 145 (4): 1988–1995. doi:10.1210/en.2003-0842. PMID 14726452.
- Upadhyay D, Bundesmann M, Panduri V, Correa-Meyer E, Kamp DW (July 2004). "Fibroblast growth factor-10 attenuates H2O2-induced alveolar epithelial cell DNA damage: role of MAPK activation and DNA repair". American Journal of Respiratory Cell and Molecular Biology. 31 (1): 107–113. doi:10.1165/rcmb.2003-0064OC. PMID 14975937.
- Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, Hilkens J (August 2004). "Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas". Oncogene. 23 (36): 6047–6055. doi:10.1038/sj.onc.1207816. PMID 15208658. S2CID 19488696.
- Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, et al. (January 2005). "Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization". Molecular and Cellular Biology. 25 (2): 671–684. doi:10.1128/MCB.25.2.671-684.2005. PMC 543411. PMID 15632068.
- Entesarian M, Matsson H, Klar J, Bergendal B, Olson L, Arakaki R, et al. (February 2005). "Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands". Nature Genetics. 37 (2): 125–127. doi:10.1038/ng1507. PMID 15654336. S2CID 36863833.
- Kovacs D, Falchi M, Cardinali G, Raffa S, Carducci M, Cota C, et al. (February 2005). "Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis". Experimental Dermatology. 14 (2): 130–137. doi:10.1111/j.0906-6705.2005.00261.x. PMID 15679583. S2CID 36797243.
- Ye F, Duvillié B, Scharfmann R (February 2005). "Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells". Diabetologia. 48 (2): 277–281. doi:10.1007/s00125-004-1638-6. PMID 15690149.
- Beer HD, Bittner M, Niklaus G, Munding C, Max N, Goppelt A, et al. (August 2005). "The fibroblast growth factor binding protein is a novel interaction partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity: implications for epithelial repair". Oncogene. 24 (34): 5269–5277. doi:10.1038/sj.onc.1208560. PMID 15806171. S2CID 75364.